U.S. consumers' out-of-pocket costs for Harvoni as of 2020, by program and coverage

In 2020, the U.S. consumer out-of-pocket costs for a monthly supply (28 tablets) of Harvoni oral tablet 90-400mg varied drastically. According to GoodRx, consumers pay an average cash retail price of 46,570 U.S. dollars for a monthly supply. In comparison, people on the "Blue Cross Blue Shield federal employees health benefit program, standard" only pay 50 U.S. dollars. Those on the "Humana Medicare part D premier Rx plan, before deductible" paid roughly 8,000 U.S. dollars for Harvoni, lying somewhere in between the two extremes. Harvoni is an antiviral agent, used to treat specific hepatitis C virus infections. This statistic shows varying consumers' out-of-pocket costs for Harvoni in the United States as of 2020, by program and coverage